Studies of progress and effectiveness

21 U.S. Code § 387u. Studies of progress and effectiveness

(a) FDA reportNot later than 3 years after June 22, 2009, and not less than every 2 years thereafter, the Secretary of Health and Human Services shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives, a report concerning—
(1)
the progress of the Food and Drug Administration in implementing this division, including major accomplishments, objective measurements of progress, and the identification of any areas that have not been fully implemented;
This document is only available to subscribers. Please log in or purchase access.